Sign in

CIK 0001501989

  • Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273521219
Phone
+1 650-515-3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-17 Young Matthew P. Director Grant or award · Stock Option (Right to Buy) +59,000 59,000
2025-06-11 Young Matthew P. Director Grant or award · Stock Option (Right to Buy) +38,000 38,000
2024-05-15 Young Matthew P. Director Grant or award · Stock Option (Right to Buy) +38,000 38,000
2023-06-14 Young Matthew P. Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2022-06-15 Young Matthew P. Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2021-06-16 Young Matthew P. Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2020-06-17 Young Matthew P. Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2019-06-19 Young Matthew P. Director Grant or award · Stock Option (Right to Buy) +14,000 14,000
2018-06-13 Young Matthew P. Director Grant or award · Stock Option (Right to Buy) +14,000 14,000
2017-06-20 Young Matthew P. Director Grant or award · Stock Option (right to buy) +14,000 14,000
2016-06-10 Young Matthew P. Director Grant or award · Stock Option (right to buy) +14,000 14,000
2015-10-07 Young Matthew P. Director Grant or award · Stock Option (right to buy) +26,985 26,985

Page 1 of 1 · 12 trades